6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reduction in the neuronal surface of post and presynaptic GABA B receptors in the hippocampus in a mouse model of Alzheimer's disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The hippocampus plays key roles in learning and memory and is a main target of Alzheimer's disease (AD), which causes progressive memory impairments. Despite numerous investigations about the processes required for the normal hippocampal functions, the neurotransmitter receptors involved in the synaptic deficits by which AD disables the hippocampus are not yet characterized. By combining histoblots, western blots, immunohistochemistry and high‐resolution immunoelectron microscopic methods for GABA B receptors, this study provides a quantitative description of the expression and the subcellular localization of GABA B1 in the hippocampus in a mouse model of AD at 1, 6 and 12 months of age. Western blots and histoblots showed that the total amount of protein and the laminar expression pattern of GABA B1 were similar in APP/PS1 mice and in age‐matched wild‐type mice. In contrast, immunoelectron microscopic techniques showed that the subcellular localization of GABA B1 subunit did not change significantly in APP/PS1 mice at 1 month of age, was significantly reduced in the stratum lacunosum‐moleculare of CA1 pyramidal cells at 6 months of age and significantly reduced at the membrane surface of CA1 pyramidal cells at 12 months of age. This reduction of plasma membrane GABA B1 was paralleled by a significant increase of the subunit at the intracellular sites. We further observed a decrease of membrane‐targeted GABA B receptors in axon terminals contacting CA1 pyramidal cells. Our data demonstrate compartment‐ and age‐dependent reduction of plasma membrane‐targeted GABA B receptors in the CA1 region of the hippocampus, suggesting that this decrease might be enough to alter the GABA B‐mediated synaptic transmission taking place in AD.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

          Beta amyloid (Abeta), a peptide generated from the amyloid precursor protein (APP) by neurons, is widely believed to underlie the pathophysiology of Alzheimer's disease. Recent studies indicate that this peptide can drive loss of surface AMPA and NMDA type glutamate receptors. We now show that Abeta employs signaling pathways of long-term depression (LTD) to drive endocytosis of synaptic AMPA receptors. Synaptic removal of AMPA receptors is necessary and sufficient to produce loss of dendritic spines and synaptic NMDA responses. Our studies indicate the central role played by AMPA receptor trafficking in Abeta-induced modification of synaptic structure and function.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

            To determine whether the presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to familial Alzheimer's disease (FAD) increase the extracellular concentration of amyloid beta-protein (A beta) ending at A beta 42(43) in vivo, we performed a blinded comparison of plasma A beta levels in carriers of these mutations and controls. A beta 1-42(43) was elevated in plasma from subjects with FAD-linked PS1 (P < 0.0001), PS2N1411 (P = 0.009), APPK670N,M671L (P < 0.0001), and APPV7171 (one subject) mutations. A beta ending at A beta 42(43) was also significantly elevated in fibroblast media from subjects with PS1 (P < 0.0001) or PS2 (P = 0.03) mutations. These findings indicate that the FAD-linked mutations may all cause Alzhelmer's disease by increasing the extracellular concentration of A beta 42(43), thereby fostering cerebral deposition of this highly amyloidogenic peptide.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Molecular structure and physiological functions of GABA(B) receptors.

              GABA(B) receptors are broadly expressed in the nervous system and have been implicated in a wide variety of neurological and psychiatric disorders. The cloning of the first GABA(B) receptor cDNAs in 1997 revived interest in these receptors and their potential as therapeutic targets. With the availability of molecular tools, rapid progress was made in our understanding of the GABA(B) system. This led to the surprising discovery that GABA(B) receptors need to assemble from distinct subunits to function and provided exciting new insights into the structure of G protein-coupled receptors (GPCRs) in general. As a consequence of this discovery, it is now widely accepted that GPCRs can exist as heterodimers. The cloning of GABA(B) receptors allowed some important questions in the field to be answered. It is now clear that molecular studies do not support the existence of pharmacologically distinct GABA(B) receptors, as predicted by work on native receptors. Advances were also made in clarifying the relationship between GABA(B) receptors and the receptors for gamma-hydroxybutyrate, an emerging drug of abuse. There are now the first indications linking GABA(B) receptor polymorphisms to epilepsy. Significantly, the cloning of GABA(B) receptors enabled identification of the first allosteric GABA(B) receptor compounds, which is expected to broaden the spectrum of therapeutic applications. Here we review current concepts on the molecular composition and function of GABA(B) receptors and discuss ongoing drug-discovery efforts.
                Bookmark

                Author and article information

                Contributors
                Rafael.Lujan@uclm.es
                Journal
                Brain Pathol
                Brain Pathol
                10.1111/(ISSN)1750-3639
                BPA
                Brain Pathology (Zurich, Switzerland)
                John Wiley and Sons Inc. (Hoboken )
                1015-6305
                1750-3639
                12 December 2019
                May 2020
                : 30
                : 3 ( doiID: 10.1111/bpa.v30.3 )
                : 554-575
                Affiliations
                [ 1 ] Synaptic Structure Laboratory Instituto de Investigación en Discapacidades Neurológicas (IDINE) Departamento de Ciencias Médicas Facultad de Medicina Universidad Castilla‐La Mancha Campus Biosanitario, C/ Almansa 14 02008 Albacete Spain
                [ 2 ] Departamento de Sistemas Informáticos Escuela Superior de Ingeniería Informática Universidad de Castilla‐La Mancha 02071 Albacete Spain
                [ 3 ] Grenoble Institut des Neurosciences Université Grenoble Alpes BP 170 Grenoble France
                [ 4 ] Department of Biomedicine Institute of Physiology University of Basel Basel Switzerland
                [ 5 ] Institute of Science and Technology (IST Austria) Am Campus 1 A‐3400 Klosterneuburg Austria
                [ 6 ] Division of Brain Structure and Function Faculty of Medical Science University of Fukui Fukui Japan
                [ 7 ] Life Science Innovation Center University of Fukui Fukui Japan
                [ 8 ] Research Center for Child Mental Development Faculty of Medical Science University of Fukui Fukui Japan
                [ 9 ]Present address: University of the Basque Country (UPV/EHU) 48940 Leioa Spain
                [ 10 ]Present address: Ikerbasque, Basque Foundation for Science 48013 Bilbao Spain
                Author notes
                [*] [* ] Corresponding author

                Rafael Luján, Synaptic Structure Laboratory, Instituto de Investigación en Discapacidades Neurológicas (IDINE), Departamento de Ciencias Médicas, Facultad de Medicina, Universidad Castilla‐La Mancha, Campus Biosanitario, C/ Almansa 14, 02008 Albacete, Spain. (E‐mail: Rafael.Lujan@ 123456uclm.es )

                Author information
                https://orcid.org/0000-0003-2001-9545
                Article
                BPA12802
                10.1111/bpa.12802
                7317930
                31729777
                cd5de097-3480-466d-b3f8-e083f845c37c
                © 2019 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 02 July 2019
                : 04 November 2019
                Page count
                Figures: 9, Tables: 0, Pages: 22, Words: 25445
                Funding
                Funded by: Ministerio de Economía y Competitividad , open-funder-registry 10.13039/501100003329;
                Award ID: BFU2015‐63769‐R
                Funded by: Horizon 2020 Framework Programme , open-funder-registry 10.13039/100010661;
                Award ID: 720270
                Award ID: 785907
                Funded by: University of Fukui , open-funder-registry 10.13039/501100005611;
                Award ID: 16H04662
                Award ID: 17K19446
                Award ID: 18H05120
                Funded by: Junta de Comunidades de Castilla‐La Mancha
                Award ID: RTI2018‐095812‐B‐I00
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                May 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:26.06.2020

                Pathology
                alzheimer's disease,electron microscopy,freeze‐fracture,gabab receptors,hippocampus,immunohistochemistry,ion channels

                Comments

                Comment on this article